Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
Primary Purpose
Sarcopenia
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Peanut protein powder
Full body resistance training
Sponsored by
About this trial
This is an interventional prevention trial for Sarcopenia focused on measuring resistance training, muscle hypertrophy, muscle quality
Eligibility Criteria
Inclusion Criteria:
- body mass index (body mass/height squared) less than 35 kg/m2
- resting blood pressure averaging less than 140/90 mmHg (with or without medication)
Exclusion Criteria:
- known peanut allergy
- actively participating in resistance training for more than 2 days/week
- any known overt cardiovascular or metabolic disease
- metal implants that will interfere with x-ray procedures
- medically necessary radiation exposure in the last six months (except dental x-ray)
- any medical condition that would contradict participating in an exercise program, giving blood or donating a skeletal muscle biopsy (i.e. blood clotting disorder or taking blood thinners)
- pregnant or trying to become pregnant
Sites / Locations
- Auburn University
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Immediate Intervention Group
Wait-list Control Group
Arm Description
Participants will complete 10 weeks of twice-weekly whole body resistance training. Peanut protein powder (72g/day) will be provided for daily consumption during the study period
Participants will complete 10 weeks of twice-weekly whole body resistance training. Peanut protein powder will be provided after the study period
Outcomes
Primary Outcome Measures
Change in acute myofibrillar protein synthesis rates
Change in right leg vastus lateralis myofibrillar protein synthesis rates using the integrated deuterium oxide technique from biopsies immediately before and 24 hours after resistance exercise
Change in right leg vastus lateralis myofibrillar protein synthesis rates using the integrated deuterium oxide technique from biopsies immediately before and 24 hours after resistance exercise
Change in mid-thigh skeletal muscle area and quality
Peripheral quantitative computed tomography (pQCT) cross-sectional image of mid-right thigh assessed for overall muscle density (mg/cm^3)
Secondary Outcome Measures
Change in appendicular lean mass
Change in lean mass (kg) of limbs as measured by dual energy x-ray absorptiometry (DXA)
Change in Type I and II Muscle Fiber Cross-Sectional Area
Muscle biopsy immunofluorescent staining for determination of type I and type II muscle fiber cross sectional area (fCSA) as a cellular determinant of skeletal muscle hypertrophy
Change in leg extensor isokinetic dynamometry
maximal isokinetic right leg extensions on an isokinetic dynamometer (BioDex)
Change in fecal microbiome composition
alpha- and beta-diversity of 16S bacterial rDNA
Full Information
NCT ID
NCT04707963
First Posted
January 10, 2021
Last Updated
June 8, 2021
Sponsor
Auburn University
Collaborators
Edward Via College of Osteopathic Medicine-Auburn, The Peanut Institute
1. Study Identification
Unique Protocol Identification Number
NCT04707963
Brief Title
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
Official Title
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
Study Type
Interventional
2. Study Status
Record Verification Date
June 2021
Overall Recruitment Status
Completed
Study Start Date
February 6, 2021 (Actual)
Primary Completion Date
May 31, 2021 (Actual)
Study Completion Date
May 31, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Auburn University
Collaborators
Edward Via College of Osteopathic Medicine-Auburn, The Peanut Institute
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This study will evaluate the adaptations in skeletal muscle that occur in response to 10 weeks of weight training with or without peanut protein supplementation in untrained men and women ages 18-30
Detailed Description
This is a two-phase study using both novel and conventional methods to assess how PP supplementation affects muscle tissue in young adults who engage in resistance training. These two phases will be conducted as part of a 10-week randomized controlled trial in which men and women aged 18-30 years (n=40), will be stratified by gender and randomized to a resistance training intervention (whole body, two days per week) with PP powder (72g daily; n=10 males, n=10 females) provided during the intervention (immediate group, IG) or after the intervention (wait-list control, WLC, n=10 males, n=10 females). The aims of this study are to determine the acute (deuterium oxide tracer) and chronic (peripheral quantitative computed tomography) effects of PP during resistance training on skeletal muscle myofibrillar protein synthesis rates, changes in skeletal muscle size and quality, changes in whole and appendicular body composition (dual energy x-ray absorptiometry), changes in inflammatory markers and the fecal microbiome.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sarcopenia
Keywords
resistance training, muscle hypertrophy, muscle quality
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Intervention group will receive the supplement during the study period and the wait-listed control group will receive the supplement after the study period. Both groups will participate in resistance training during the 10 week period
Masking
InvestigatorOutcomes Assessor
Masking Description
PI and Co-Is will be blind to participant randomization. One study staff member will be responsible for administering the supplements to participants per randomization
Allocation
Randomized
Enrollment
56 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Immediate Intervention Group
Arm Type
Experimental
Arm Description
Participants will complete 10 weeks of twice-weekly whole body resistance training. Peanut protein powder (72g/day) will be provided for daily consumption during the study period
Arm Title
Wait-list Control Group
Arm Type
Active Comparator
Arm Description
Participants will complete 10 weeks of twice-weekly whole body resistance training. Peanut protein powder will be provided after the study period
Intervention Type
Dietary Supplement
Intervention Name(s)
Peanut protein powder
Intervention Description
Peanut protein powder will be provided to participants who will be instructed to consume 72g daily, mixed with water
Intervention Type
Behavioral
Intervention Name(s)
Full body resistance training
Intervention Description
Participants will undergo supervised resistance training two times per week (5 exercises, 3 sets of 8-12 repetitions per set)
Primary Outcome Measure Information:
Title
Change in acute myofibrillar protein synthesis rates
Description
Change in right leg vastus lateralis myofibrillar protein synthesis rates using the integrated deuterium oxide technique from biopsies immediately before and 24 hours after resistance exercise
Change in right leg vastus lateralis myofibrillar protein synthesis rates using the integrated deuterium oxide technique from biopsies immediately before and 24 hours after resistance exercise
Time Frame
24 hours
Title
Change in mid-thigh skeletal muscle area and quality
Description
Peripheral quantitative computed tomography (pQCT) cross-sectional image of mid-right thigh assessed for overall muscle density (mg/cm^3)
Time Frame
0-10 weeks
Secondary Outcome Measure Information:
Title
Change in appendicular lean mass
Description
Change in lean mass (kg) of limbs as measured by dual energy x-ray absorptiometry (DXA)
Time Frame
0-10 weeks
Title
Change in Type I and II Muscle Fiber Cross-Sectional Area
Description
Muscle biopsy immunofluorescent staining for determination of type I and type II muscle fiber cross sectional area (fCSA) as a cellular determinant of skeletal muscle hypertrophy
Time Frame
0-10 weeks
Title
Change in leg extensor isokinetic dynamometry
Description
maximal isokinetic right leg extensions on an isokinetic dynamometer (BioDex)
Time Frame
0-10 weeks
Title
Change in fecal microbiome composition
Description
alpha- and beta-diversity of 16S bacterial rDNA
Time Frame
0-10 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
30 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
body mass index (body mass/height squared) less than 35 kg/m2
resting blood pressure averaging less than 140/90 mmHg (with or without medication)
Exclusion Criteria:
known peanut allergy
actively participating in resistance training for more than 2 days/week
any known overt cardiovascular or metabolic disease
metal implants that will interfere with x-ray procedures
medically necessary radiation exposure in the last six months (except dental x-ray)
any medical condition that would contradict participating in an exercise program, giving blood or donating a skeletal muscle biopsy (i.e. blood clotting disorder or taking blood thinners)
pregnant or trying to become pregnant
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael D Roberts, PhD
Organizational Affiliation
Associate Professor
Official's Role
Principal Investigator
Facility Information:
Facility Name
Auburn University
City
Auburn
State/Province
Alabama
ZIP/Postal Code
36849
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
Deidentified anthropometric, physiological, biological and performance data may be requested
Citations:
PubMed Identifier
34836236
Citation
Sexton CL, Smith MA, Smith KS, Osburn SC, Godwin JS, Ruple BA, Hendricks AM, Mobley CB, Goodlett MD, Fruge AD, Young KC, Roberts MD. Effects of Peanut Protein Supplementation on Resistance Training Adaptations in Younger Adults. Nutrients. 2021 Nov 9;13(11):3981. doi: 10.3390/nu13113981.
Results Reference
derived
Learn more about this trial
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
We'll reach out to this number within 24 hrs